A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...
Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...
NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...
An Alabama Senate bill advances to mandate insurance coverage for prostate cancer screenings, potentially improving early ...
Scott Adams, creator of "Dilbert," has died at 68 due to prostate cancer complications. He faced backlash for racial comments before his death but continued to create a self-published comic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results